Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production-Reference-Cited by-同舟云学术

Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production

Published:2021-08-06 Issue:32 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Senapati Sujata¹^ORCID,Darling Ross J.²^ORCID,Ross Kathleen A.¹³^ORCID,Wannemeuhler Michael J.²³^ORCID,Narasimhan Balaji¹³^ORCID,Mallapragada Surya K.¹³^ORCID

Affiliation:

1. Department of Chemical and Biological Engineering, Iowa State University, Ames, IA, USA.

2. Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, USA.

3. Nanovaccine Institute, Iowa State University, Ames, IA, USA.

Abstract

Self-assembling nanoadjuvant scaffolds cross-link B cell receptors and are a new platform technology for therapeutic antibodies.

Funder

National Institutes of Health

Nanovaccine Institute, Iowa State University

Publisher

American Association for the Advancement of Science (AAAS)

Subject